The COVID-19 pandemic has created numerous challenges for everyone worldwide. In this current environment, clinical trials must adapt to changing conditions and innovate for the future. Our CEO Dr. Joanne Santomauro was interviewed on the how critical the ancillary supply chain is to overall success and how more emphasis must be placed on ensuring supply chain execution before study kick-off.

As published in PharmaVOICE